Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease

By Schapira A.  

Human Molecular Genetics, Vol. 10, Iss. 17, 2001-08 ,pp. : 1829-1845

Oxford University Press

Access to resources Recommend Favorite

Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington’s disease gene

By Kovtun Irina V.  

Human Molecular Genetics, Vol. 9, Iss. 18, 2000-11 ,pp. : 2767-2775

Oxford University Press

Access to resources Recommend Favorite

Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin

By Wang Hongmin   Lim Precious J.   Vogel Bruce E.   Monteiro Mervyn J.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 1025-1041

Oxford University Press

Access to resources Recommend Favorite

Cholinergic neuronal defect without cell loss in Huntington's disease

By Smith Ruben   Chung Hinfan   Rundquist Sara   Maat-Schieman Marion L.C.   Colgan Lesley   Englund Elisabet   Liu Yong-Jian   Roos Raymund A.C.   Faull Richard L.M.   Brundin Patrik   Li Jia-Yi  

Human Molecular Genetics, Vol. 15, Iss. 21, 2006-11 ,pp. : 3119-3131

Oxford University Press

Access to resources Recommend Favorite

Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease

By Gaughwin Philip Michael   Ciesla Maciej   Lahiri Nayana   Tabrizi Sarah J.   Brundin Patrik   Björkqvist Maria  

Human Molecular Genetics, Vol. 20, Iss. 11, 2011-06 ,pp. : 2225-2237

Oxford University Press

Access to resources Recommend Favorite